A spotlight on women's health

Content by PhRMA: Biopharmaceutical researchers are working on a potential new therapy that could help women cope with moderate to severe vasomotor symptoms (VMS).
Why it's important
Up to 80% of women in the U.S. - 26 million women each year - experience VMS due to menopause.
The biopharmaceutical industry has a key role to play in advancing future treatments for unmet needs in women’s health.